23andMe Holding Co. (ME) - כמות מזומנים למניה

Management crises and conflicts with leadership are undermining investor confidence. The daily price action for cash per share on the GURU.Markets chart shows that the value remains at 3.01. 23andMe Holding Co. (ME) relies on DNA test sales and partnerships with pharma behemoths, protecting its business with a unique archive of biodata that creates a powerful barrier to entry for new market players.
פילוחי מדדים מקיפים ואנליטיקה עבור 23andMe Holding Co (ME)

The investment attractiveness of 23andMe Holding Co. (ME) is based on the monetization of genetic data arrays. This metric determines the share of liquid reserves per common share. Analyzing cash per share over the period allows for an assessment of the business's intrinsic value relative to its market price. Digital report logistics minimize operating expenses, freeing up cash for development. A high level of this metric confirms the company's financial stability.